Precigen (PGEN) Net Margin Growth (5y) (2017 - 2026)
Precigen (PGEN) Net Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,257.00 |
| Dec 31, 2025 | -29,202.00 |
| Sep 30, 2025 | -3.45 Mn |
| Jun 30, 2025 | -332,040.00 |
| Mar 31, 2025 | -392,045.00 |
| Dec 31, 2024 | 24,848.00 |
| Sep 30, 2024 | -239.78 Mn |
| Jun 30, 2024 | -817,954.00 |
| Mar 31, 2024 | -218,803.00 |
| Sep 30, 2022 | 73,852.00 |
| Jun 30, 2022 | 32,551.00 |
| Mar 31, 2022 | 14,480.00 |
| Dec 31, 2021 | 8,112.00 |
| Sep 30, 2021 | -4,209.00 |
| Jun 30, 2021 | 38,072.00 |
| Mar 31, 2021 | 16,884.00 |
| Dec 31, 2020 | 7,341.00 |
| Sep 30, 2020 | 6,477.00 |
| Jun 30, 2020 | 157.00 |
| Mar 31, 2020 | -19,404.00 |